← Back to Search

Peaceful Coexistence for Antiextremism

N/A

Recruiting

Research Sponsored by University of North Carolina, Greensboro

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately post intervention

Awards & highlights

Study Summary

This trial will use an innovative, engineering-inspired methodological approach, the Multiphase Optimization Strategy (MOST), to optimize and evaluate the Peaceful Coexistence and Anti-Extremism middle and high school curricula with the goal that the optimized versions of these curricula will be used across the Kingdom of Bahrain and translated for use in other countries to combat the spread of extremism and intolerance.

Eligible Conditions

Antiextremism
Active Citizenship
Social Norms
Resistance Training
Open-mindedness
Drug Tolerance
Decision Making
Empathy
Literacy
Cognitive Distortions

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately post intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately post intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Beliefs about consequences

Community values

Decision making

+9 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Classrooms assigned to the intervention group will receive the Peaceful Coexistence (middle school) or Anti-extremism (high school) curricula.

Group II: No interventionActive Control1 Intervention

Classrooms assigned to the No intervention group will receive general information during their sessions.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of North Carolina, GreensboroLead Sponsor

31 Previous Clinical Trials

15,141 Total Patients Enrolled

Media Library

Peaceful Coexistence Clinical Trial Eligibility Overview. Trial Name: NCT05088694 — N/A

Peaceful Coexistence 2023 Treatment Timeline for Medical Study. Trial Name: NCT05088694 — N/A

Antiextremism Research Study Groups: Intervention, No intervention

Antiextremism Clinical Trial 2023: Peaceful Coexistence Highlights & Side Effects. Trial Name: NCT05088694 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any restrictions on the number of participants accepted into this research trial?

"Correct. According to clinicaltrials.gov, this medical study is currently recruiting for 1500 participants from a single site. This trial was originally posted on November 1st 2021 and the information has been recently updated on November 2nd 2022."

Answered by AI

Does this research project permit individuals over the age of 25 to take part?

"This trial is open to minors aged 11-18. There are eight trials specifically for young people and ten studies that target the elderly population above 65 years of age."

Answered by AI

Are any additional participants being sought for the present trial?

"As evidenced on clinicaltrials.gov, enlistment for this medical study is currently underway. The trial was first published to the website in November 2021 and has been updated most recently as of November 2022."

Answered by AI

Could I be a participant in this experiment?

"Eligibility requirements for this trial demand that patients are literate and within the range of 11-18 years old. The researchers aim to recruit a total of 1500 participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Optimization and Evaluation of the Extremism and Intolerance Curriculum for the Kingdom of Bahrain.

Jeffrey Milroy 2021. "The Optimization and Evaluation of the Extremism and Intolerance Curriculum for the Kingdom of Bahrain.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05088694.